Annual Meeting

Please join us for the 30th Annual Meeting of the American Society for Bone and Mineral Research in Montréal, Quebéc, Canada. This year's program will be held September 12 - September 16, 2008, at the Palais des congrès de Montréal. Don't miss this opportunity to meet and mingle with more than 5,000 clinicians and researchers from around the world at the premier meeting for bone and mineral science!

The ASBMR Official Scientific Program will feature oral presentations, poster presentations and Meet-the-Professor sessions, as well as Working Groups, lectures, and symposia.

Back to Top

Venue

All Annual Meeting sessions and events will take place in the Palais des congres de Montréal, located at 1159, rue Saint-Antoine Ouest, 9e étage, Montréal, Quebéc, Canada, unless otherwise stated in the Preliminary Program or On-site Program book.

Back to Top

Awards

Thank you for your interest in the ASBMR 30th Annual Meeting. The abstract deadline has now passed. Thank you for your submissions.

Abstracts-Related Awards

Only first/presenting authors will be considered for the following awards.

Although nominations are not accepted for the following awards, abstract submitters should indicate their eligibility on the abstract submission form. The members of the Program Committee select the award winner based only on the scientific merit of the abstract. All abstracts are scored using a "blind-review system" as described in detail in the Abstracts book. These awards will be presented at the Annual Meeting.

ASBMR Young Investigator Awards recognize young investigators for their excellence in bone and mineral research. Nominations are not accepted. To select the award winners, ASBMR identifies the eligible investigators whose abstracts attained the highest ranked positions within their respective categories, using the abstract reviewers' "blind-review system" of scoring abstracts as described in the Abstracts book. Initial award designations are preliminary, and are finalized contingent upon validation of eligibility criteria and presentation of the abstract by the young investigator at the annual meeting.

Award Recipients must:

1) be the first AND presenting author of the abstract
2) be within five years of completion of a Ph.D. or of clinical training for M.D., D.D.S., or equivalent
3) have never before been a recipient of either an ASBMR Young Investigator Award

The five years of eligibility are defined to extend from the end of the calendar year of the date of graduation or, if applicable, of completion of residency training or clinical subspecialty fellowship training, to the submission deadline date. 

Clinical subspecialty fellowship training is considered to end no later than the point at which the individual becomes board eligible. 

The above eligibility criteria include students or trainees who have not yet obtained their doctoral degree.

Individuals with special circumstances, e.g., for whom postdoctoral research did not commence within one year of graduation or, if applicable, of completion of clinical training, may petition the ASBMR to consider an extension of the term of eligibility defined above. However, petitions to the ASBMR regarding award eligibility must occur prior to the submission of the abstract (prior to April 16, 2008).

The award includes a $1,000 honorarium and a plaque. The ASBMR expects that $500 of the honorarium will be used to help offset travel expenses to the Annual Meeting. The other $500 may be used by the recipient at his/her discretion.

The ASBMR Most Outstanding Abstract Award is given to the highest ranking abstract. The award includes a $1,500 honorarium and a plaque. (One award is given per year).

The ASBMR Award for Outstanding Research in the Pathophysiology of Osteoporosis is given to the highest ranking abstract in the Osteoporosis: Pathophysiology abstract category.  The award includes a $1,500 honorarium and a plaque. (One award is given per year).

The ASBMR President's Award is given to the highest ranking abstract by a student. The award includes a $1,500 honorarium and a plaque. (One award is given per year).

Other ASBMR Awards

ASBMR will present other major Society awards at the meeting that recognize individuals for their outstanding work in the field of bone and mineral research and for dedication to the Society (Louis V. Avioli Founders Award, Fuller Albright Award, Frederic C. Bartter Award, William F. Neuman Award, Shirley Hohl Service Award, the Gideon A. Rodan Excellence in Mentorship Award, and the ASBMR Early Career Excellence in Teaching Award). The deadline for these awards have passed, thank you for your nominations. For further information, contact the ASBMR Business Office at (202) 367-1161 or visit the ASMBR Awards page.

Back to Top

Continuing Medical Education (CME)

This activity is being planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME), so that physicians attending the ASBMR 30th Annual Meeting will be able to apply for continuing medical education credits (CME). 

More information about CME and the Annual Meeting will be available shortly.

For more information, please contact the ASBMR Business Office.

Purpose Statement
The purpose of the ASBMR 30th Annual Meeting is to allow attendees to present new developments in education, research and clinical practice related to bone and mineral metabolism, bone and stem cell biology and children’s bone health issues.

Learning Objectives
Upon completion of this activity, participants should be able to...

• Recognize past, present and future developments in bone and mineral research
• Discuss the most current and significant advances in biomedical and clinical research in bone and mineral metabolism in the areas of bone and stem cell biology, cancer, mineral metabolism, genetics, bioengineering, osteoporosis, metabolic bone diseases and therapeutics.
• Explain enhanced strategies for the diagnosis and treatment of patients with disorders of bone and mineral metabolism
• Describe issues related to children’s bone health and bone mass accrual

Target Audience

The program is designed for researchers, physicians, clinicians, and other allied health professionals with interests in endocrinology, physiology, cell biology, pathology, molecular biology, genetics, epidemiology, internal medicine, rheumatology, orthopaedics, dentistry, nephrology, and pharmacology.

Disclosure Policy

The ASBMR is committed to ensuring the balance, independence, objectivity and scientific rigor of all its individually sponsored or industry-supported educational activities. ASBMR receives its sponsorship of Continuing Medical Education through the Medical Education Collaborative (MEC). MEC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. To ensure that this activity meets ACCME requirements, individuals who are in a position to control the content must disclose relationships with a commercial interest if the individual has the opportunity to affect CME content about the products or services of that commercial interest with which he/she has or has had a financial relationship within the past 12 months. Disclosure must be made by all planning committee members, speakers, authors, and others in a position to influence or control content. Failure to respond will make you ineligible to participate in the planning, development or delivery of content. This information will be disclosed to participants.

Disclosure should include any relationship that may bias one’s presentation or which, if known, could give the perception of bias. These situations may include, but are not limited to: 1) Speaker’s Bureau; 2) Consulting Fees or other remuneration (payment); 3) Paid Research; 4) Advisory Committee or other paid committee; 5) Other.

ASBMR’s Expectations of Authors and Presenters      

Through ASBMR meetings, the Society promotes excellence in bone and mineral research. Toward that end, ASBMR expects that all authors and presenters affiliated with the ASBMR 30th Annual Meeting and the 2008 Ancillary Program will provide informative and fully accurate content that reflects the highest level of scientific rigor and integrity. This includes the presentations at the Ancillary Meetings.

The ASBMR depends upon the honesty of the authors and presenters and relies on their assertions that they have had sufficient full access to the data and are convinced of its reliability.

Furthermore, the ASBMR expects that:

• Authors and presenters will disclose any conflicts of interest, real or perceived.
• Authors and presenters describing a study funded by an organization with a proprietary or financial interest must affirm that they had full access to all the data in the study. By so doing, they accept complete responsibility for the integrity of the data and the accuracy of the data analysis.
• The content of abstracts, presentations, slides, and reference materials must remain the ultimate responsibility of the authors and presenters.
• The planning, content and execution of abstracts, speaker presentations, slides, abstracts and reference materials should be free from corporate influence, bias, or control. 
• All authors and presenters (invited and abstracts-based oral and poster presenters) should give a balanced view of therapeutic options by providing several treatment options, whenever possible, and by always citing the best available evidence.

In addition, ASBMR’s meeting evaluations will seek feedback regarding commercial bias at ASBMR’s Annual Meeting sessions.

Back to Top

ASBMR Embargo Policy

Abstracts submitted to the ASBMR 30th Annual Meeting are embargoed — that is, unavailable for public release in written, oral and electronic communications — until one hour after the abstract has been presented.

The ASBMR is sensitive to issues of commercial confidentiality and relevant aspects of the U.S. Securities and Exchange Commission (SEC) regulations. Therefore, the ASBMR reminds all readers that all must adhere to the U.S. Securities and Exchange Commission regulations and treat all scientific information as confidential until the embargo has been lifted – one hour after the abstract has been presented. Any reader of, or listener to, ASBMR Annual Meeting content may be viewed as an “insider” by the SEC due to knowledge of information included in abstracts, particularly clinical trial abstracts. SEC regulations may call for criminal penalties for using such information.

Back to Top

2007 Supporters

The ASBMR gratefully acknowledges the following companies and organizations for their support:

Diamond Level
Amgen, Inc.
Eli Lilly and Company

Gold Level
Alliance for Better Bone Health (Procter & Gamble
Pharmaceuticals and sanofi-aventis)

Silver Level
Roche and GSK
Pfizer, Inc.  
Novartis Pharmaceuticals Corporation

Bronze Level
AbbottPharmaceuticals
Merck & Co., Inc.

Friend Level
GlaxoSmithKline
GlaxoSmithKline Consumer Healthcare
Immunodiagnostics Systems
Merck Research Laboratories
Mission Pharmacal Company
Pfizer, Inc.
Procter & Gamble Pharmaceuticals
sanofi-aventis
Wyeth Pharmaceuticals

Back to Top

Advertising

If you are interested in learning about advertising opportunities in the Journal of Bone and Mineral Research, please contact:

Steve Kavalgian
Mill River Media
Phone: (860) 434-6889,
Fax: (860) 434-9744,
E-mail: millrivermedia@aol.com,
Website: www.jbmr-online.org

Back to Top